Emyria LtdASX: EMD

Emyria Enters Data Deal with ZLD to Support Autism Trial

· Issued by Emyria Ltd

Filed with ASX · · 3 pages · English

Highlights: ● Observational trial will collect efficacy and safety data from patients with Autism Spectrum Disorder (ASD) that have been prescribed one or more HOPE™ products ● Leverages Emyria’s real-world data expertise and national network of clinics – Emerald Clinics - to facilitate patient access ● Emyria data to inform product development and evaluation of a path to registration ● Partnershi

Emyria Ltd on 6ix

Story so far

Earlier from Emyria

Later from Emyria

All Emyria news releases